Identifying Biologic Targets to Attenuate or Eliminate Asthma Exacerbations

Similar documents
Effects of omalizumab on RV infections, illnesses, and exacerbations of asthma. James Gern, MD Ann Esquivel, MD University of Wisconsin, Madison

Biologic Therapy in the Management of Asthma. Nabeel Farooqui, MD

Searching for Targets to Control Asthma

Distinction and Overlap. Allergy Dpt, 2 nd Pediatric Clinic, University of Athens

Immunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine

Biologics in Asthma: Present and Future

Defining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness

Do We Need Biologics in Pediatric Asthma Management?

IL-33 Dependent Type 2 Inflammation during Rhinovirus-induced Asthma Exacerbations In Vivo

Asthma Management for the Athlete

The Link Between Viruses and Asthma

Different kinds of asthma, different kinds of therapies

Using Patient Characteristics to Individualize and Improve Asthma Care

Phenotypes of asthma; implications for treatment. Medical Grand Rounds Feb 2018 Jim Martin MD DSc

This is an author-submitted, peer-reviewed version of a manuscript that has been accepted for publication in the European Respiratory Journal, prior

Allergen and Environment in Severe Asthma

Personalized medicine in childhood asthma. Dr Mariëlle Pijnenburg, Erasmus MC Sophia, Rotterdam, NL

Biologics in asthma Are we turning the corner? Roland Buhl Pulmonary Department Mainz University Hospital

Viral infections and asthma: an inflammatory interface?

Traiter l asthme sévère par le phénotype. Dr. Alain Michils CUB-Hôpital Erasme

E-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling

Jamie Lee Memorial Lecture ( ) Targets and Outcomes: Mepolizumab, Benralizumab, Reslizumab

Which asthma patient has allergic airway inflammation?

What is the best way to treat recurrent wheeze in pre-school children?

Airway Inflammation in Asthma Chih-Yung Chiu 1,2, Kin-Sun Wong 2 1 Department of Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan.

Defining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness

Defining Asthma: Bronchial Hyperresponsiveness. Defining Asthma: Clinical Criteria. Impaired Ventilation in Asthma. Dynamic Imaging of Asthma

Exhaled Nitric Oxide: An Adjunctive Tool in the Diagnosis and Management of Asthma

Impact of Asthma in the U.S. per Year. Asthma Epidemiology and Pathophysiology. Risk Factors for Asthma. Childhood Asthma Costs of Asthma

Clinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy

SEVERE ASTHMA NUCALA 100MG SUBCUTANEOUS INJECTION THE FIRST TARGETED ANTI IL-5 ADD-ON TREATMENT FOR ADULTS WITH SEVERE REFRACTORY EOSINOPHILIC ASTHMA

Viral infections in airway remodeling

Asthma Publications: Year in Review

Viral-Induced Asthma:

Infections in children with asthma

Severe Asthma(s): Can THEY be prevented or reversed?

Disclosures. Learning Objective. Biological therapies. Biologics with action against 11/30/2011. Biologic Asthma Therapies and Individualized Medicine

Bronchial asthma. E. Cserháti 1 st Department of Paediatrics. Lecture for english speaking students 5 February 2013

Current Asthma Therapy: Little Need to Phenotype. Phenotypes of Severe Asthma. Cellular Phenotypes 12/7/2012

Asthma COPD Overlap (ACO)

Omalizumab (Xolair ) ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September Indication

At least 3 of the following criteria:

Allergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

Management of wheeze in pre-school children. Prof Colin Robertson, Respiratory Medicine, Royal Children s Hospital, Melbourne

Distinguishing Type-2 Asthma

Property of Presenter

Suitable Patient Populations and Study Designs for rapid PoC

Update on Immunology 12/31/12. Disclosures. Outline. Outline. Outline. Pathophysiology of Allergic Disease. Allergy background Novel T cell subsets

Su-Ling Loo, Peter A.B. Wark

Asthma and Its Many Unmet Needs: Directions for Novel Therapeutic Approaches

Appendix E1. Epidemiology

What is Asthma? Chronic disease of the airways that may cause Wheezing Breathlessness Chest tightness Night time or early morning coughing

Outcome, classification and management of wheezing in preschool children Paul L.P. Brand

The role of dendritic cells in asthma

Are emerging PGD2 antagonists a promising therapy class for treating asthma?

NG80. Asthma: diagnosis, monitoring and chronic asthma management (NG80)

Allergic rhinitis (Hay fever) Asthma Anaphylaxis Urticaria Atopic dermatitis

Vitamina D: un ormone multifunzione

VIRUSES AND ASTHMA. They asked if the sneezle came after the wheezle, or if the first sneezle came first

Diagnosis and Management of Fungal Allergy Monday, 9-139

Pediatric Asthma: Pharmacotherapy. Joseph Spahn, MD Children s Hospital Colorado & University of Colorado Medical School Aurora, Colorado

COPD and Asthma: Similarities and differences Prof. Peter Barnes

Current Asthma Management: Opportunities for a Nutrition-Based Intervention

Recurrent Wheezing in Preschool Children. William Sheehan, MD Associate Professor of Pediatrics Division of Allergy and Immunology

n Definition of asthma control n Main causes of asthma exacerbations n Physiopathology & treatment targets n How to prevent/manage exacerbations

TREAMENT OF RECURRENT VIRUS-INDUCED WHEEZING IN YOUNG CHILDREN. Dr Lại Lê Hưng Respiratory Department

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton

Exhaled Nitric Oxide Today s Asthma Biomarker. Richard F. Lavi, MD FAAAAI FAAP

Immunomodulators: Anti-IgE mab. Thomas B. Casale, MD Professor of Medicine Chief, Allergy/Immunology Creighton University Omaha, NE

1/30/2016 RESPIRATORY INFECTIONS AND ASTHMA NO DISCLOSURES NO FINANCIAL INTEREST INFORMATION OBTAINED JACI AJRCCM

Pathology of Asthma Epidemiology

an inflammation of the bronchial tubes

SEVERE ASTHMA - EVIDENCE TABLES APPENDIX 1

Viral infections in wheezing disorders

New Therapies for Asthma

EFFECTIVE ASTHMA MANAGEMENT IN PRIMARY CARE Severity Assessment, Guidelines, and New Therapeutic Options

Impaired innate interferon induction in severe therapy resistant atopic asthmatic children

A comparison of seasonal trends in asthma exacerbations among children from geographic regions with different climates

Asthma Pathophysiology and Treatment. John R. Holcomb, M.D.

Airway eosinophils in older teenagers with outgrown preschool wheeze: a pilot study

Potential public health impact of RSV vaccines. R. Karron December 2016

Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit)

Allergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.

Systems Pharmacology Respiratory Pharmacology. Lecture series : General outline

Prof Neil Barnes. Respiratory and General Medicine London Chest Hospital and The Royal London Hospital

Diet, Obesity and Asthma

Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing

Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses

10/24/2016. Precision Management of Severe Asthma How, When and Where. The Goals of Today s Presentation

The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils

COPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013

Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ

Early life nutrition and Inflammation

Immunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008

Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air

Running head: COMMON COLD AND BRONCHITIS 1

Clinical Evaluation of Leukotriene Receptor Antagonists in Preventing Common Cold-like Symptoms in Bronchial Asthma Patients

Asthma Hetereogeneity, Phenotypes and Endotypes Choosing the Right Biologic for your Patient

Pulmonary Perspective

The immunology of virus infection in asthma

Transcription:

Identifying Biologic Targets to Attenuate or Eliminate Exacerbations exacerbations are a major cause of disease morbidity and costs. For both children and adults, viral respiratory infections are the major cause of these exacerbations. The mechanisms underlying these episodes are complex and involve multiple cells and factors. With the use of biologics to treat more severe asthma and exacerbation-prone patients, greater insight has been gained into the targets, and consequently, the mechanisms by which respiratory viruses, particularly the common cold virus rhinovirus, lead to exacerbations. The following discussion on biologic targets for exacerbations will focus on major risk factors in this process: IgE, allergic sensitization, deficiencies in innate immunity, particularly interferon generation, and the multiple cells and pathways involved. The unfolding of this new information has not only provided greater insight to this major cause of asthma morbidity, and its loss of control, but also is identifying new targets whose targeted control promises to lead to improved outcomes and the attenuation or prevention of exacerbations. What are key biologic targets in Environment (Seed) Respiratory virus (Rhinovirus) Allergens Host (Soil) IgE (Allergic sensitization) Diminished innate immune response Eosinophils (T2) Inflammatory mediators What role does IgE play in What is the effect of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus? What is the effect of omalizumab on asthma exacerbations on a seasonal basis? % of Participants with Exacerbations (n=211) (n=28) Soto-Quiros, et al. J Allergy Clin Immunol 212;129:1499 155 Busse WW and Morgan WJ, et al. N Engl J Med 211;364:15-159 Bronchial Epithelial Cells + Respiratory Viruses What role do innate immune responses play in Virus Replication Generation of Interferon-λ Baraldo et al. J Allergy Clin Immunol 212; 13:137-1314.

Total Serum IgE Levels Is dendritic cell (pdc) generation of IFN-α antiviral impaired in patients with allergic asthma? IFN-α pg/ml Influenza A IFN-α pg/ml 9 6 3 H-16 P =.1 Baraldo et al. J Allergy Clin Immunol 212; 13:137-1314. Control Control J. Immunol., 21, 184 (11), 5999-6. What is the relationship between IgE and virus induced IFN α generation? What effect does omalizumab have on seasonal exacerbations of asthma in PROSE? H FLU Total IgE (KU/L) Teach, SJ et al. J Allergy Clin Immunol 215; 136:1476-1485 What effect does omalizumab treatment have on in vitro generation of IFN-α from isolated PBMC incubated with? What is the effect of restoring IFN-α generation to Geometric mean IFN-α level 2 1 5 2 1 5 Placebo Omalizumab OR 1.19 (95% CI.49 2.88) OR 3.22 (95% CI 1.23 8.45) n=23 n=56 n=23 n=56 Pre-randomization Post-randomization Teach, SJ et al. J Allergy Clin Immunol 215;136:1476-1485 Patients with exacerbations (%) 35 3 25 2 15 1 5 Omalizumab post-randomization 21. OR.14 (95% CI.1.88) 2. < median (n=28) > median (n=28) IFN-α increase Teach, SJ et al. J Allergy Clin Immunol 215;136:1476-1485

Is there a difference in bronchial epithelial cell generation of interferon between normal and asthma? Normal Impaired IFN- production in asthma Replication Apoptosis Generation interferon- (Anti-viral) Wark et al. J Exp Med 25; 21:937-947. Wark et al. J Exp Med 25; 21:937-947. Djukanović R, et al. The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. Am J Respir Crit Care Med 214;19:145-154. = IFN-β = Placebo Djukanović et al. Am J Resp Crit Care Med 214;19:145-154. What is the alveolar macrophage expression of interferon-β to in severe asthma? = IFN-β = Placebo Djukanović et al. Am J Resp Crit Care Med 214;19:145-154. Rupani H., et al. Am J Respir Crit Care Med 216;194:26-37.

What is the comparative of TLR7 protein generation by AM to in severe asthma? Is there a relationship between TLR7 expression by AM and frequency of exacerbation in severe asthma? Rupani H., et al. Am J Respir Crit Care Med 216;194:26-37. Rupani H., et al. Am J Respir Crit Care Med 216;194:26-37. What is the comparative AM expression of mirnas in healthy and severe asthma subjects? Alteration of alveolar macrophage generation of interferons mirnas TLR7 AM IFN ( ) Rupani H., et al. Am J Respir Crit Care Med 216;194:26-37. What is the relationship of blood eosinophils to severe Pavord ID, et al. Mepolizumab (anti-il-5) for severe eosinophilic asthma (DREAM). Lancet 212;38:651-59. Evaluated mepolizumab (75, 25 and 75 mg) vs. placebo 621 adult patients on high doses of ICS and with one or more of the following 2 or more exacerbations in previous year Sputum eosinophils >3% Increased susceptibility FeNO >5 ppb factors for Blood eosinophils >3/microliter exacerbations Price DB, et al. Lancet Respir Med 215;3:849-58.

What is the effect of a infection on asthma, eosinophils, IL-33 and IL-5? A B C Jackson DJ, et al. Am J Respir Crit Care Med 214;19:1373-1382 Pavord ID, et al. Lancet 212;38:651-659. How may anti-il-5 affect virus-induced Viruses X = Anti-IL-5 What are key biologic targets that may promote Airway Inflammation mirna IL-33 TLR7 ILC2 IL-5 X Epithelium Dendritic Cells AM IFNs IFNs IFNs Eosinophil Th2 IL-5 X Anti-IL-5 Eosinophil Virus Suppression Inflammation IL-4, IL-9, IL-13 Exacerbation